Biography
Dr Maria Billert is a graduate of Applied Biology with a specialization in Experimental Biology at the Poznan University of Life Sciences in Poznan. During her PhD studies she investigated the role of phoenixin as a regulator of adipoinsular axis elements, under the supervision of Marek Skrzypski PhD hab. She obtained with honours her PhD in biological sciences from the Poznan University of Life Sciences in Poland. Part of her PhD thesis was financed by the Preludium research grant for young scientists, which she received from the National Science Centre in Poland. In this project she explored the role of phoenixin as a new regulator of alpha and beta cells. Her research interests are concentrated around neuropeptides involved in energetic metabolism and its role on beta cells biology. She works as a post-doc in Professor Shanta Persaud research project and is involved in research on the role of C1QL1-derived proteins and peptides as a potential treatment of type 2 diabetes.
Research
Islet Biology Research Group
Our group studies the fundamental science of islets of Langerhans, from the molecular biology of beta-cells to their effects on whole body physiology. We research the mechanisms of islet dysfunction during type 2 diabetes and gestational diabetes, identify novel therapeutic targets, and work to improve islet transplantation therapy for type 1 diabetes.
Research
Islet Biology Research Group
Our group studies the fundamental science of islets of Langerhans, from the molecular biology of beta-cells to their effects on whole body physiology. We research the mechanisms of islet dysfunction during type 2 diabetes and gestational diabetes, identify novel therapeutic targets, and work to improve islet transplantation therapy for type 1 diabetes.